With this research we examined the activity of cefepime/zidebactam (WCK 5222) against consecutive reference laboratory submissions of Gram-damaging germs, taken being a sample of difficulty strains circulating in the united kingdom. Use our demo look for to uncover descriptions of clinical trials, taking part demo clinics, their recruitment standing and https://lennys009gsd2.blogrenanda.com/profile